284 related articles for article (PubMed ID: 34415658)
1. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H
J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861
[TBL] [Abstract][Full Text] [Related]
3. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
4. The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR).
Sturt P; Suh YE; Khoo V
Med Dosim; 2022 Summer; 47(2):173-176. PubMed ID: 35277316
[TBL] [Abstract][Full Text] [Related]
5. Plan comparison of prostate stereotactic radiotherapy in spacer implant patients.
Oki Y; Uehara K; Mizonobe K; Akasaka H; Shiota Y; Sakamoto R; Harada A; Kitatani K; Yabuuchi T; Miyazaki S; Hattori T; Mayahara H
J Appl Clin Med Phys; 2021 Sep; 22(9):280-288. PubMed ID: 34359100
[TBL] [Abstract][Full Text] [Related]
6. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
8. A dosimetric comparison for SBRT plans of localized prostate cancer between Cyberknife and Varian Truebeam STX device.
Şenişik AM; Okutan M; Çakir A; Iribaş Çelik A; Kaytan Sağlam E; Çevikbaş G; Demir B
Appl Radiat Isot; 2023 Feb; 192():110617. PubMed ID: 36538872
[TBL] [Abstract][Full Text] [Related]
9. Sequential monoscopic image-guided motion compensation in tomotherapy stereotactic body radiotherapy (SBRT) for prostate cancer.
Lu L; Chao E; Zhu T; Wang AZ; Lian J
Med Phys; 2023 Jan; 50(1):518-528. PubMed ID: 36397645
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy using the forward-planned static-port tomotherapy for lung cancer: a novel planning technique with the newly-developed mode.
Manabe Y; Miyakawa A; Kondo T; Yamada Y; Hashimoto S; Ishikura S; Shibamoto Y
J Radiat Res; 2020 Nov; 61(6):993-998. PubMed ID: 33210148
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy in prostate cancer: is rapidarc a better solution than cyberknife?
Macdougall ND; Dean C; Muirhead R
Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):4-9. PubMed ID: 24071450
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.
Seppälä J; Suilamo S; Tenhunen M; Sailas L; Virsunen H; Kaleva E; Keyriläinen J
Technol Cancer Res Treat; 2017 Apr; 16(2):238-245. PubMed ID: 28279147
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP
Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
[TBL] [Abstract][Full Text] [Related]
15. Cyberknife, Helical Tomotherapy and Rapid Arc SIB-SBRT Treatment Plan Comparison for Carcinoma Prostate.
T K B; K M G; A P; C A M
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1149-1154. PubMed ID: 32334484
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer.
Chen CY; Lee LM; Yu HW; Lee SP; Lee HL; Lin YW; Wen YC; Chen YJ; Chen CP; Tsai JT
J Xray Sci Technol; 2017; 25(3):465-477. PubMed ID: 28157113
[TBL] [Abstract][Full Text] [Related]
17. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer.
Serra M; Ametrano G; Borzillo V; Quarto M; Muto M; Di Franco R; Federica S; Loffredo F; Paolo M
Medicine (Baltimore); 2020 Dec; 99(50):e23574. PubMed ID: 33327317
[TBL] [Abstract][Full Text] [Related]
19. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
[TBL] [Abstract][Full Text] [Related]
20. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
